实用肝脏病杂志 ›› 2023, Vol. 26 ›› Issue (4): 472-475.doi: 10.3969/j.issn.1672-5069.2023.04.005

• 实验性肝炎 • 上一篇    下一篇

抗菌肽抑制Caspase-3表达对内毒素诱导的急性肝衰竭小鼠肝细胞凋亡的影响*

仁增卓嘎, 王志鑫, 尹凤娇, 王海久   

  1. 810001 西宁市 青海大学附属医院肝胆胰外科(仁增卓嘎,王志鑫,尹凤娇,王海久);拉萨市人民医院肝胆胰外科(仁增卓嘎)
  • 收稿日期:2023-02-06 出版日期:2023-07-10 发布日期:2023-07-21
  • 通讯作者: 王海久,E-mail:wanghaijiuqy@126.com
  • 作者简介:仁增卓嘎,女,30岁,医学硕士,医师。E-mail:zg1050510140@163.com
  • 基金资助:
    *青海省科技厅临床医学研究中心资助项目(编号:2017-SF-L2)

Protection of mice with endotoxin-induced acute liver failure by antimicrobial peptide through inhibiting cell apoptosis

Ren Zengzhuoga, Wang Zhixin, Yin Fengjiao, et al   

  1. Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital, Qinghai University, Xining 810001, Qinghai Province, China
  • Received:2023-02-06 Online:2023-07-10 Published:2023-07-21

摘要: 目的 探讨抗菌肽Cathelicidin-PY对脂多糖(LPS)/D-氨基半乳糖(D-GalN)诱导的急性肝衰竭(ALF)小鼠的保护作用及其可能的作用机制。 方法 取60只C57BL/6小鼠,随机分为对照组、模型组、小剂量Cathelicidin-PY干预组(1.0 mg.kg-1)和大剂量Cathelicidin-PY干预组(3.0 mg.kg-1),每组15只。采用LPS/D-GalN腹腔联合注射构建小鼠ALF模型,其中干预组在注射LPS/D-GalN前2 h经尾静脉注射Cathelicidin-PY。在造模后5 h,每组取5只小鼠采集血标本和肝组织,记录剩余小鼠24 h存活情况。采用ELISA法检测血清肿瘤坏死因子α(TNF-α)和白细胞介素1β(IL-1β)水平,采用TUENL染色法检测肝细胞凋亡,采用Western blot法检测肝组织半胱氨酸天冬氨酸蛋白酶3剪切体(cleaved caspase-3)蛋白表达。 结果 小剂量和大剂量Cathelicidin-PY干预组小鼠24 h存活率为40%(4/10)和60%(6/10),均显著高于模型组的10.0%(1/10,P<0.05);模型组小鼠血清TNF-α和IL-1β水平分别为(1069.4±178.0)pg/mL和(1354.1±162.9)pg/mL,显著高于对照组【分别为(140.7±33.6)pg/mL和(436.2±46.8)pg/mL,P<0.05】,而小剂量和大剂量Cathelicidin-PY干预组血清TNF-α和IL-1β水平均显著低于模型组(P<0.05);模型组小鼠肝细胞凋亡数量和Cleaved caspase-3蛋白表达均较对照组显著增多或增强(P<0.05),而小剂量和大剂量Cathelicidin-PY干预组肝细胞凋亡数量和Cleaved caspase-3蛋白表达均较模型组显著减少或减弱(P<0.05)。 结论 Cathelicidin-PY能通过减轻炎症反应和抑制肝细胞凋亡,改善LPS/D-GalN诱导的ALF小鼠肝损伤,降低动物死亡率。

关键词: 急性肝衰竭, Cathelicidin-PY, 凋亡, 抑菌肽, 半胱氨酸天冬氨酸蛋白酶3, 小鼠

Abstract: Objective The aim of this study was to explore the protective effect and possible mechanism of antimicrobial peptide cathelicidin-PY in mice with lipopolysaccharide (LPS)/D-galactosamine (D-GalN)-induced acute liver failure (ALF). Methods 60 C57BL/6 mice were randomly divided into control, model, low-dose cathelicidin-PY (1.0 mg.kg-1) –intervention and high-dose cathelicidin-PY (3.0 mg.kg-1) intervention group, with 15 mice in each group. The models of ALF in mice were established by intraperitoneal injection of LPS/D-GalN, and in intervention groups 2 hours before injection of LPS/D-GalN, the mice were injected with cathelicidin-PY via the tail vein. At 5 hours after LPS/D-GalN injection, the blood samples and liver tissues were collected in 5 sacrificed mice in each group, and the survivals within 24 hours of the residual mice was recorded in each group. Serum tumor necrosis factor α (TNF-α) and interleukin-1β (IL-1β) levels were detected by ELISA, and the apoptosis of liver cells was detected by TUENL staining. The expression of cleaved cysteine proteinase 3 (cleaved caspase-3) in liver tissues was detected by Western blot. Results The 24 h survival rates in low-dose and high-dose cathelicidin-PY intervention groups were 40% (4/10) and 60% (6/10), significantly higher than 10.0% (1/10, P<0.05) in the model; serum TNF-α and IL-1β levels in the model group were (1069.4±178.0) pg/mL and (1354.1±162.9) pg/mL, both significantly higher than [ (140.7 ± 33.6) pg/mL and (436.2 ± 46.8) pg/mL, respectively, P<0.05] in the control, while serum TNF-α and IL-1β levels in the low-dose and high-dose cathelicidin-PY intervention groups decreased significantly compared to in model group (P<0.05); the numbers of apoptotic liver cells and expression of cleaved caspase-3 protein in liver tissues in the model group increased significantly (P<0.05) compared to in the control, while the numbers of apoptotic liver cells decreased, and the expression of cleaved caspase-3 protein became weak significantly compared to in the model in the low-dose and in the high-dose cathelicidin-PY intervention group (P<0.05). Conclusion The antimicrobial peptide, the cathelicidin-PY could reduce mortality in mice with LPS/D-GalN-induced ALF, probably by relieving inflammation response and inhibiting apoptosis of liver cells.

Key words: Acute liver failure, Antimicrobial peptide, Cathelicidin-PY, Apoptosis, Cysteine proteinase 3, Mice